Effects of interleukin-1, tumor necrosis factor -beta, and forskolin on tissue plasminogen activator activity in human osteoblastic osteosarcoma cells
- PMID: 1571831
- DOI: 10.1007/BF00298789
Effects of interleukin-1, tumor necrosis factor -beta, and forskolin on tissue plasminogen activator activity in human osteoblastic osteosarcoma cells
Abstract
The effects of interleukin-1 (IL-1), forskolin, and tumor necrosis factor beta (TNF-beta) on tissue plasminogen activator (t-PA) activity were studied in the human osteoblastic osteosarcoma cell line, G292. t-PA activity was measured in the cell media using the chromogenic substrate, S-2251. After a 24 hour incubation period, IL-1 increased t-PA in a dose-dependent manner. The effect of IL-1 at 10.0 U/ml was partially inhibited in the presence of indomethacin. Forskolin (1.0 microM) increased t-PA activity after 24 hours with the effects of combined treatment of IL-1 (1.0 U/ml, 10.0 U/ml) and forskolin being apparently additive in nature. TNF-beta (10(-8)-10(-7)M) also produced increased t-PA activity in the cell media after a 24 hour incubation period. These results suggest that the cytokines, IL-1 and TNF-beta, can increase t-PA activity in G292 cells and that there is both a cAMP-dependent as well as a cAMP-independent pathway involved in the regulation of this osteoblastic cell function.
Similar articles
-
The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63.J Bone Miner Res. 1992 Dec;7(12):1363-71. doi: 10.1002/jbmr.5650071203. J Bone Miner Res. 1992. PMID: 1481722
-
Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.J Bone Miner Res. 1995 Sep;10(9):1374-84. doi: 10.1002/jbmr.5650100915. J Bone Miner Res. 1995. PMID: 7502710
-
Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells.Calcif Tissue Int. 1991 Nov;49(5):321-7. doi: 10.1007/BF02556254. Calcif Tissue Int. 1991. PMID: 1723649
-
Effects of interleukin-1 alpha on arachidonic acid metabolism in human osteosarcoma osteoblastic cells.Prostaglandins Leukot Essent Fatty Acids. 1993 Jul;49(1):521-6. doi: 10.1016/0952-3278(93)90041-t. Prostaglandins Leukot Essent Fatty Acids. 1993. PMID: 8395696
-
Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.Anticancer Res. 1997 May-Jun;17(3A):1461-5. Anticancer Res. 1997. PMID: 9179184 Review.
Cited by
-
The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study.Anat Embryol (Berl). 1995 Oct;192(4):363-8. doi: 10.1007/BF00710105. Anat Embryol (Berl). 1995. PMID: 8554169